The transition from one medical device to another can have significant repercussions, especially for those living with chronic conditions like diabetes. I personally rely on the Dexcom G6 sensors to manage my blood glucose levels effectively. Recently, I learned about the potential discontinuation of the Dexcom G6 scheduled for July 1, 2026, and I am deeply concerned.

The launch of the Dexcom G7 in 2023 has, unfortunately, been fraught with inconsistencies and a tragic track record. According to data available at https://hntrbrk.com/dexcom2/ there have already been 13 reported deaths of diabetics using the G7. This is alarming and unacceptable. As someone managing diabetes, having a reliable tool is not just a preference—it's a necessity.

The Dexcom G6, in comparison, has been a reliable and trustworthy device for many people. Its accuracy and consistency provide essential peace of mind to those who depend on it every day. The discontinuation of such a vital tool could result in increased health risks and anxiety for countless individuals who might find themselves without a viable alternative.

I am urging Dexcom to reconsider their decision and keep the G6 sensors in production beyond July 1, 2026. Ensuring patients have continued access to dependable glucose management technology can prevent unnecessary health crises and save lives.

By signing this petition, we can collectively voice our needs and concerns to ensure the safety and health of all diabetic patients relying on Dexcom technology. Your support can make a difference. Let's urge Dexcom to prioritize patient safety and keep the G6 in production.